STEPHANIE BEECHING: Open Payments
NPI 1275953002 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 76 payments from 10 companies in 2025. Trend: 2023 $2,351 · 2024 $1,688 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $263 |
| Teva Pharmaceuticals USA, Inc. | 27 | $245 |
| ABBVIE INC. | 21 | $228 |
| Vanda Pharmaceuticals Inc. | 4 | $82 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Lundbeck LLC | 2 | $46 |
| Alkermes, Inc. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
Products named: REXULTI, VRAYLAR, UZEDY, AUSTEDO XR, Auvelity, ABILIFY MAINTENA, COBENFY, HETLIOZ.
Industry payments across OH — which companies pay providers there.
